Specialists for High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement

3 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Thomas E Witzig, M.D.
Rare Disease Specialist
Mayo Clinic Health Systems-Mankato
Mankato, Minnesota
QC-verified
Stephen M Ansell, M.D
Rare Disease / Clinical Research
Dana-Farber - Harvard Cancer Center LAO
ROCHESTER, MN
PI×1 5
Reem Karmali, MD, MD
Rare Disease / Clinical Research
Northwestern University
CHICAGO, IL
PI×6

More about High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement

Disease overview →
Treatments →
Clinical trials →